Topical composition comprising dutasteride and latanoprost for alopecia
A topical composition of dutasteride and latanoprost addresses the limitations of current AGA treatments by providing synergistic hair growth and loss prevention, offering faster and thicker hair growth benefits.
AE202602059APendingGLENMARK SPECIALTY
0 Cites 0 Cited by
Patent Information
- Application Number
- AE202602059
- Authority / Receiving Office
- AE · AE
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-12-19
- Filing Date
- 2024-12-17
AI Technical Summary
Technical Problem
Current treatments for androgenetic alopecia (AGA) are often expensive, time-consuming, and may have side effects, with no cure available, and there is a need for more effective methods to prevent hair loss and stimulate hair growth.
Method used
A topical composition combining a 5α-reductase inhibitor, such as dutasteride, with a prostaglandin analogue, such as latanoprost, to target different aspects of the hair loss process, potentially providing more comprehensive treatment for AGA.
Benefits of technology
The combination of dutasteride and latanoprost shows enhanced hair growth and prevention of hair loss, with faster onset and thicker hair growth compared to individual treatments, demonstrating improved efficacy over existing options.
✦ Generated by Eureka AI based on patent content.
Abstract
The present invention relates to the use of combination of 5α-reductase inhibitors and prostaglandin analogues for preventing hair loss and / or stimulating hair growth. The present invention also relates to topical composition containing 5α-reductase inhibitors and prostaglandin analogues for preventing hair loss and / or stimulating hair growth on the scalp. The present invention also relates to composition and methods for treating certain hair loss disorders such as androgenetic alopecia.
Need to check novelty before this filing date? Find Prior Art